Bayer plans German launch of new stroke drug despite healthcare spending cuts
read at Endpoints ↗Neutral
Bayer announced it will move forward with the launch of its new stroke medication in Germany.
The decision comes even though Germany has introduced a new healthcare spending bill that reduces reimbursement levels, which Bayer has criticized.
Bayer said the drug will be introduced in “every country possible,” indicating a broader global rollout plan despite the fiscal constraints.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Bayer eyes German launch of stroke drug despite spending cuts in the country”
read at Endpoints ↗84 words · retrieved 4h ago
comments(0)
5-min edit window · permanent after that